Sponsorluk

Bharat Bio successfully completes Phase III trials of new oral cholera vaccine Hillchol

Bharat Biotech's oral cholera vaccine, Hillchol, has demonstrated successful Phase III clinical trial results, proving effective against both Ogawa and Inaba serotypes. The vaccine exhibited a significant rise in vibriocidal antibodies and maintained a strong safety profile across all age groups. With production capacity of 200 million doses, Hillchol can address the global cholera crisis and vaccine shortages.
Site içinde arama yapın
Kategoriler
Read More
Fan frenzy for Vaibhav Suryavanshi: Two girls drive 6 hours to meet him
India's Under-19 cricket sensation, Vaibhav Suryavanshi, is capturing hearts both on and off the...
By BharatUpdates 0 1
‘Backbone of city’: Philadelphia union workers end strike; reach ‘historic deal’ with city
Philadelphia officials and District Council 33 have reached a tentative agreement, ending a...
By BharatUpdates 0 32
Aditya shares vacay pics; fans ask 'who is the mystery girl?'
Aditya Roy Kapur's recent photo dump on social media has ignited a frenzy among fans, who are...
By BharatUpdates 0 39
Cricket meets tennis! Bumrah watches Wimbledon with wife Sanjana ahead of Lord’s Test
Ahead of the crucial Lord's Test, Indian cricket stars, including India's premier pacer and his...
By BharatUpdates 0 39
'We defend Raavana for the first time': Raj on Yash's Ramayana
Nitesh Tiwari’s ambitious project Ramayana has been making waves in the entertainment...
By BharatUpdates 0 50